TY - JOUR
T1 - Inactivation of protease-activated receptor-1 by proteolytic removal of the ligand region in vascular endothelial cells
AU - Nakayama, Tetsuzo
AU - Hirano, Katsuya
AU - Hirano, Mayumi
AU - Nishimura, Junji
AU - Kuga, Hirotaka
AU - Nakamura, Katsuya
AU - Takahashi, Shosuke
AU - Kanaide, Hideo
N1 - Funding Information:
We thank Mr. Brian Quinn for linguistic comments and help with the manuscript. This study was supported in part by the 21st Century Center of Excellence Program and Grants-in-Aid for Scientific Research (Nos. 13470149, 14657174, 14570675, 15590758) from the Ministry of Education, Culture, Sports, Science and Technology, Japan, by the Research Grant for Cardiovascular Diseases (13C-4) from the Ministry of Health, Labour and Welfare, Japan, and by grants from the Japan Space Forum and the Naito Foundation.
PY - 2004/7/1
Y1 - 2004/7/1
N2 - Proteolysis plays an important role in inactivating protease-activated receptor-1 (PAR1). We aimed to determine the cleavage site(s) responsive for the proteolytic inactivation of PAR1 in human umbilical vein endothelial cells. Fura-2 fluorometry revealed that the preceding stimulation with trypsin abolished the subsequent [Ca2+]i response to thrombin, while the responses to PAR1-activating peptides remained intact. On the other hand, thrombin had no effect on the subsequent response to trypsin. The immunostaining with antibodies against the residues 35-46 (SPAN12) and 51-64 (WEDE15) revealed the broad boundaries of cleavage. Trypsin removed both epitopes from the cell surface within 3 min, while thrombin removed the epitope of SPAN12. The longer incubation with thrombin removed the epitope of WEDE15. However, PAR1-activating peptides thereafter induced an attenuated but significant elevation of [Ca2+]i. Not only the receptor internalization as observed with a confocal microscope, but also an additional cleavage was thus suggested to contribute to the thrombin-induced removal of the epitope of WEDE15. The analyses of the PAR1 mutants identified three cleavage sites for trypsin; residues 41-42, 70-71 and 82-83. The cleavage at the latter two sites was suggested to dominate that at the former, and thus remove the ligand region (residues 42-47). The inactivation of PAR1 due to proteolytic removal of the ligand region may contribute not only to the inactivation of PAR1 by proteases such as trypsin, but also to the termination of the intracellular signaling initiated by thrombin in the vascular endothelial cells.
AB - Proteolysis plays an important role in inactivating protease-activated receptor-1 (PAR1). We aimed to determine the cleavage site(s) responsive for the proteolytic inactivation of PAR1 in human umbilical vein endothelial cells. Fura-2 fluorometry revealed that the preceding stimulation with trypsin abolished the subsequent [Ca2+]i response to thrombin, while the responses to PAR1-activating peptides remained intact. On the other hand, thrombin had no effect on the subsequent response to trypsin. The immunostaining with antibodies against the residues 35-46 (SPAN12) and 51-64 (WEDE15) revealed the broad boundaries of cleavage. Trypsin removed both epitopes from the cell surface within 3 min, while thrombin removed the epitope of SPAN12. The longer incubation with thrombin removed the epitope of WEDE15. However, PAR1-activating peptides thereafter induced an attenuated but significant elevation of [Ca2+]i. Not only the receptor internalization as observed with a confocal microscope, but also an additional cleavage was thus suggested to contribute to the thrombin-induced removal of the epitope of WEDE15. The analyses of the PAR1 mutants identified three cleavage sites for trypsin; residues 41-42, 70-71 and 82-83. The cleavage at the latter two sites was suggested to dominate that at the former, and thus remove the ligand region (residues 42-47). The inactivation of PAR1 due to proteolytic removal of the ligand region may contribute not only to the inactivation of PAR1 by proteases such as trypsin, but also to the termination of the intracellular signaling initiated by thrombin in the vascular endothelial cells.
UR - http://www.scopus.com/inward/record.url?scp=2942587085&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=2942587085&partnerID=8YFLogxK
U2 - 10.1016/j.bcp.2004.03.005
DO - 10.1016/j.bcp.2004.03.005
M3 - Article
C2 - 15183114
AN - SCOPUS:2942587085
SN - 0006-2952
VL - 68
SP - 23
EP - 32
JO - Biochemical Pharmacology
JF - Biochemical Pharmacology
IS - 1
ER -